Radosław Dzida

CPL207280, a Novel G Protein–Coupled Receptor 40/Free Fatty Acid Receptor 1–Specific Agonist, Shows a Favorable Safety Profile and Exerts Antidiabetic Effects in Type 2 Diabetic Animals

B. Kamińska, M. Wieczorek, M. Matłoka, 2021, Molecular Pharmacology.

– a novel GPR 40 / FFA 1-specific agonist shows a favorable safety profile and exerts anti-diabetic effects in type 2 diabetic animals

M. Wieczorek, M. Matłoka, K. Dubiel, 2021 .

Discovery and development of CPL207280 as new GPR40/FFA1 agonist.

M. Wieczorek, M. Matłoka, Urszula Dawid, 2021, European journal of medicinal chemistry.